Diluting Methadone To Liquid Form – Practice, Negative Impact, Diversion

The dilution of methadone with water was initiated as a result of the first federal methadone regulations because it was believed that this policy would reduce the diversion of methadone. While initially this policy may have had an impact within a short time most prospective buyers learning that methadone was now diluted with water and how to measure the amount of drug. Therefore diluting methadone with another solution usually sterile water has had a minimal impact on methadone diversion while creating other consequences that were not anticipated.

Comments on Methadone Diversion

Concern or rather the over-concern about methadone diversion has created a number of policies that programs and patients must adhere to while doing very little to reduce diversion. First it must be emphasized that the great majority of methadone patients take their medication as prescribed and do not sell or give it to anyone else. Therefore these policies have had a far-reaching impact on patients that are compliant.

System proposes that if diversion is of such concern to the federal and state agencies that “real efforts” be made to make methadone available to everyone that needs it. Studies have demonstrated that diverted methadone is typically purchased by addicts who are not able to get into treatment for whatever reason (i.e. wait lists, documentation, cost, program policy, believe methadone myths) (John Galea, Street Research Unit, OASAS, personal communication 2003). Instead of creating policies that make program policies more rigid and controlling and thus less attractive to prospective patients efforts should be focused on how to make treatment available to everyone that needs it. With the majority of dependent opioid addicts in methadone treatment the need for illicit methadone would cease. In countries where citizens have a right to medical and health care and methadone treatment is integrated into the medical system illicit methadone does not exist. It makes no sense for an addict to pay for something that is free and easily available (M. Reisinger, personal communication, 2002).

Methadone Dilution – Negative Impact

The dilution of methadone has a negative psychological impact on methadone patients and therefore results in a policy that is anti-therapeutic. No other medication is diluted in such a manner. Every time that a patient gets their medication — that is often diluted in front of them — a message is communicated to them that they are different than other medical patients and untrustworthy. Thus the program is forced to participate in a procedure that contributes to the low self-esteem of methadone patients. Former addicts may also harbor anxieties about their medication being diluted without their permission or that someone is diverting it from the clinic because they were subjected to practices like this (A Byrne, personal conversation, 2002).

Having one’s methadone dispensed in a pure form is reassuring to the patient that they are being treated like any other medical patient. Programs must come to realize that for methadone patients it is utmost importance that they be treated like any other medical patient. Diluting methadone has the potential to induce or worsen anxieties and even minor symptoms could be thought by the patient to be due to drug effects. Thus the treatment program has become the vehicle that promotes the same anxieties that the patient underwent while on the street.

Diluting methadone also has an impact that is rarely discussed because of the ramifications. Particularly when methadone is diluted and bottled prior to the patients coming to the clinic there is greater possibility of it being diverted by clinic staff. While such instances are rare they do occur as noted in a New York Times article in which a pharmacist was siphoning off the drugs he prepared for financial reasons (11/18/01). Almost every patient in methadone treatment has at least thought about this and the possibility that nursing or pharmacy staffs were diluting their methadone. System receives about eight complaints a year from patients suspicious about their medication. Since System has no investigative unit it is difficult to confirm how often these instances are occurring. However, the number of complaints indicates that a problem exists and that administering methadone in its standard form reduces suspicion and is reassuring for patients that they are treated like other medical patients.

Conclusion

Therefore System encourages programs to re-think their policy of diluting methadone. It is harmful to the psychic health of their patients who are constantly suspicious of the program and motives of the staff. Ending theses policies can only help to improve the therapeutic alliance that is necessary between patients and programs and improve the quality of treatment. It will also work towards reducing the stigma and elevate methadone treatment and the professionals working in it to their rightful place as a legitimate medical procedure.

References

New York Times, November 18, 2001. Prosecutors Say Greed Drove Pharmacist to Dilute Drugs, page 1.

 

[Download PDF] 

[Next Policy Statement]

[Index Policy Statements]

Similar Posts

  • The First Patient Advocate’s Illumination Award Sunday, October 7th

    Admin 12/19/2021

    The First Patient Advocate’s Illumination Award Sunday, October 7th The Advocate’s Illumination Award is presented to an individual and/or treatment program whose persistence in the search of solutions to the myriad problems of addictive disease, has significantly improved the experience and outcome of treatment. Inscription The Opioid Agonist Treatment Advocacy Community with heartfelt thanks and…

  • National Alliance of Methadone Advocates

    Admin 02/12/2023

    NAMA is an organization composed of methadone patients and health care professionals that are supporters of quality opiate agonist treatment. We have thousands of members worldwide with a network of international affiliated organizations and chapters in many places in the United States. The primary objective of NAMA is to advocate for the patient in treatment…

  • Methadone Take Home Bottle Recall

    Admin 02/17/2023

    The intent of Bottle Recall initially was to be able to allow patients take home medication and to insure that methadone is not diverted to the streets. However, methadone programs have been giving patients take home medication for years without a serious methadone diversion problem. Furthermore numerous studies have demonstrated that methadone is not a…

  • Publication Index

    Admin 03/18/2022

    FOR IMMEDIATE RELEASE: October 9, 2002 NIDA Contact: Michelle Person 301-443-6245 SAMHSA Contact: Leah Young 301-443-8956 NIDA Research and SAMHSA Physician Training Combine to Put Care for Opiate Dependence in Hands of Family Doctor. Buprenorphine, a new medication developed through more than a decade of research supported by the National Institute on Drug Abuse (NIDA),…

  • Myths About Methadone by Emmett Velten-3

    Admin 08/01/2022

    These facts were important, of course, to Dole and Nyswander, but were completely crucial in their long battle to get government to go along with the idea of methadone maintenance.  Government reflects Americans practical tendency as well as its moralistic, judgmental tendency, and in this case the practical tendency can out on top.  Government allowed…

  • State Agencies & Regulation Information

    Admin 10/19/2021

      Alabama Division of Substance Abuse Services Home Page http://www.mh.state.al.us/services/sa/sa-main_html Alaska Division of Alcoholism and Drug Abuse Home Page http://health.hss.state.ak.us/dada/ Alaska Regulations http://www.touchngo.com/lglcntr/akstats/acc/title07chapter033.htm Arizona Bureau of Substance Abuse Treatment and Prevention Services Home Page http://health.state.az.us/ Index http://www.hs.state.az.us/bhs/index.htm Arkansas Division of Treatment Services Bureau of Alcohol and Drug Abuse Prevention Home Page http://www.healthyarkansas.com/ Arkansas Regulations http://www.healthyarkansas.com/index.html…